#United States #Class Action #San Francisco #Legal Notice #Opioid Settlement

Major $180 Million Settlement for Third-Party Payors

Three notable law firms, Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, have announced a substantial class action settlement amounting to $180 million. This settlement directly impacts third-party payors—organizations or entities that have incurred or reimbursed costs related to prescription opioids. This announcement comes after allegations against opioid manufacturers for misrepresenting the risks associated with long-term opioid use, and claims regarding improper oversight by pharmaceutical distributors and pharmacies.

Who is Eligible?

If you are a third-party payor that has financed or reimbursed costs for prescription opioids or have paid for treatments related to opioid misuse, addiction, or overdose, you may qualify for a share of the settlement. This includes various entities such as:

• - Private contractors of Federal Health Employee Benefits plans
• - Self-insured local government entities not involved in prior claims in MDL No. 2804
• - Managed Medicaid plans
• - Medicare Part C and/or D plans
• - Taft-Hartley plans
• - ERISA plans

However, note that certain governmental entities, pharmacy benefit managers, consumers, and fully insured plan sponsors are excluded from this classification.

The class period spans January 1, 1996 to June 16, 2026, so if your payments or incurred costs fall within this timeframe, you might be eligible for compensation.

Settlement Allocation

The settlement funds will cover multiple aspects including:

• - Payments to eligible third-party payors (TPP Class Members)
• - Notice and administrative costs
• - Attorneys' fees and associated expenses
• - Service awards to Class Representatives

A total of $180 million has been earmarked for these purposes, providing financial relief to those affected by the fallout of opioid misuse.

How to Claim Your Share

If you believe you are eligible to claim part of the settlement, you must submit a claim form either online or by mail. Claims must be postmarked by December 1, 2026 to qualify for payments. If you have previously filed a claim in the TPP class settlement with settling distributors, you can utilize that information when submitting your claim in this settlement.

For further details on how to file your claim, or if you need to check your eligibility, you can visit the official settlement website at www.TppOpioidSettlement.com.

Important Dates and Rights

Even if you choose not to participate in this settlement, you may still be bound by the court's decisions. If you wish to retain your right to pursue legal action against any of the settling defendants, it is crucial to exclude yourself from the settlements by August 13, 2026. Additionally, you can voice your comments or objections regarding the settlements up until that date.

A court hearing is scheduled for September 23, 2026, at 12:00 PM, to discuss the approval of the settlements and the attorney's fees requested, which could reach up to 20% of the settlement funds. You may appear at the hearing, either personally or through your own legal counsel, at your expense. Keep checking the settlement website for any updates on deadlines or hearing details.

For more information, you can contact the support line at 1-877-411-4860 or visit the official site mentioned above. Don’t miss this opportunity if you are among those who have been financially burdened due to opioid-related expenses.

In summary, this landmark settlement not only provides substantial financial support for those affected by opioid misuse and related health costs but also reinforces the accountability of pharmaceutical companies within the industry.